GE HealthCare Technologies Inc. Common Stock vs TotalEnergies SE — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $68.66 (market cap $31.07B), while TotalEnergies SE trades at $89.31 (market cap $196.57B). The key difference: TotalEnergies SE is far larger — about 6.3× GE HealthCare Technologies Inc. Common Stock's market cap, and TotalEnergies SE pays the higher dividend (4.76%). Which is the better fit depends on your goals.
| GEHC | TTE | |
|---|---|---|
Market Cap | $31.07B | $196.57B |
Volume | 3,443,020 | 2,606,285 |
Sector | Health | Energy |
52-Week High | $88.16 | $93.60 |
52-Week Low | $59.48 | $60.44 |
Enterprise Value | $39.53B | $227.56B |
Dividend Yield | 0.23% | 4.76% |
Typical Hold Time | — | 91 Days |
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
TotalEnergies (TTE) trades at $89.64, up 1.44% today, with a bullish technical outlook and strong analyst support. The stock shows robust fundamentals with a P/E of 11.13 and net income margin of 9.08%, though revenue has declined from $263.3B in 2022 to $182.3B in 2025. Recent news highlights a $10B investment in Argentina and a $2.5B Q4 share buyback increase, reinforcing growth commitments. Earnings have beaten expectations in two of the last three quarters, with Q3 2026 results pending.
The outlook for TTE is positive, driven by strategic investments and shareholder returns, but faces risks from volatile energy prices and execution challenges. Wall Street consensus is bullish with a $95.33 price target, though investors should monitor oil price fluctuations and geopolitical factors that could impact profitability.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →TotalEnergies is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2021, it produced 1.5 million barrels of liquids and 7.2 billion cubic feet of natural gas per day. At year-end 2020, reserves stood at 12.1 billion barrels of oil equivalent, 45% of which are liquids. During 2021, it had LNG sales of 42 Mt. The company owns interests in refineries with capacity of nearly 1.8 million barrels a day, primarily in Europe, distributes refined products in 65 countries, and manufactures commodity and specialty chemicals. It also holds a 19% interest in Russian oil company Novatek. At year-end, its gross installed renewable power generation capacity was 10.3 GW.
Read more on TTE →